Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 307.10
+7.50 (2.50%)
At close: Jul 31, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 80.99 billion as of July 31, 2026. Its market cap has increased by 31.28% in one year.
Market Cap
80.99B
Enterprise Value
75.97B
Revenue
71.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
307.10
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 80.99B, an increase of 4,925.67%. That is a compound annual growth rate of 17.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 80.99B | 113.39% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 244.64B |
| Shilpa Medicare | 119.61B |
| IOL Chemicals and Pharmaceuticals | 42.91B |
| Gujarat Themis Biosyn | 39.10B |
| Sai Parenteral's | 24.19B |
| NGL Fine-Chem | 20.17B |
| Bajaj HealthCare | 11.33B |
| Shree Ganesh Remedies | 8.11B |